Our findings also confirmed that CRISPR-Cas9-mediated GFI1-KO or shRNA-mediated GFI1-KD also induced differentiation markers and morphologic features of differentiation in AML cells, albeit to a lesser extent than knockout or knockdown of LSD1. Here, GFI1 is linked to acute myeloid leukemia.